Advertisement
Getaway Seminar is an educational professional event for registered nurses, bringing together healthcare practitioners for advanced discussions in metabolic disease, HIV treatment, and chronic central nervous system inflammation. Hosted at Paris Las Vegas in Las Vegas, United States, the seminar is designed for a USA-based audience and features Stan Louie, a pharmacy and biomedical sciences expert. Dr. Louie earned his Doctorate in Pharmacy from the University of California, San Francisco, completed pharmacy residency training at Pacific Presbyterian Medical Center, and pursued molecular biology research at the Kuzell Institute. He later joined the University of Southern California, where his work examined cytokine regulation associated with tumor and viral proliferation. He is an Associate Professor at the USC School of Pharmacy and Keck School of Medicine, focusing on HIV, hepatitis B and C, brain cancer drug discovery, and multiple myeloma treatment development.The seminar’s metabolic disease program examines the shift from lifestyle-only obesity management toward disease-modifying pharmacotherapy. Sessions address updated terminology surrounding metabolic dysfunction-associated steatotic liver disease and steatohepatitis, along with therapeutic advances involving resmetirom and semaglutide. Additional topics include the role of obesity therapies in cardiovascular disease prevention and emerging developments in incretin combinations, lipid-lowering treatments, lipoprotein(a), anti-inflammatory therapy, biomarkers, and precision metabolic medicine.
A dedicated HIV program explores how antiretroviral therapy suppresses viral replication without eliminating latent reservoirs. Participants will review integrase inhibitor-based regimens, long-acting injectable therapies, capsid inhibitors, and the distinctions among viral suppression, functional cure, and sterilizing cure. Current eradication strategies include latency reversal, immune-based treatments, broadly neutralizing antibodies, gene editing, and stem-cell approaches, together with the scientific, clinical, and ethical challenges that continue to limit progress.
The program also examines chronic inflammation in the central nervous system, distinguishing it from acute protective inflammation. It considers the roles of microglia, astrocytes, neurons, oligodendrocytes, endothelial cells, and peripheral immune cells in neurodegeneration, demyelination, synaptic dysfunction, and blood-brain barrier disruption. Comparative discussions address multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, traumatic brain injury, and aging, while highlighting emerging biomarkers, imaging techniques, and therapeutic strategies targeting neuroinflammation.
Advertisement
Event venue
Paris Las Vegas, 3655 S Las Vegas Blvd, Las Vegas, NV 89109, USA, United States
Tickets